Hyperprolactinemia with aripiprazole: a case report and review of the literature
Hyperprolactinemia is an important but often a neglected side effect of antipsychotic treatment. Aripiprazole is one of the new atypical antipsychotics that has partial agonist effects on dopamine D2 receptors and has a low possibility of hyperprolactinemia. In the present case report, we discuss a...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Mesut Çetin
2021-02-01
|
| Edice: | Psychiatry and Clinical Psychopharmacology |
| Témata: | |
| On-line přístup: | https://psychiatry-psychopharmacology.com/index.php/pub/article/view/901 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|